| ALK | Anaplastic lymphoma kinase |
| AP-1 | Activator protein-1 |
| ATM | Ataxia telangiectasia mutated |
| BC | Breast cancer |
| BMK-1 | Big mitogen-activated protein kinase 1 |
| BNIP3 | BCL2 interacting protein 3 |
| BNIP3L | BNIP3 like |
| CCA | Cholangiocarcinoma |
| CCRC | Clear cell renal carcinoma |
| CDKi | Cyclin-dependent protein kinase inhibitor |
| CML | Chronic myeloid leukemia |
| COX2 | Cyclooxygenase 2 |
| CRC | Colorectal cancer |
| DDIAS | DNA-damage-induced apoptosis suppressor |
| EGF | Epidermal growth factor |
| E-cad | E-cadherin |
| EMT | Epithelial-to-mesenchymal transition |
| ERK5 | Extracellular signal-regulated kinase 5 |
| ERα | Estrogen receptor α |
| FAK | Focal adhesion kinase |
| FGF | Fibroblast growth factor |
| GSK3 | Glycogen synthase kinase 3 |
| HCC | Hepatocellular carcinoma |
| HGF | Hepatocyte growth factor |
| IL | Interleukin |
| MAPK | Mitogen-activated protein kinase family |
| MEF-2 | Myocyte enhancer factor 2 |
| MHC-I | Major histocompatibility complex class I |
| MM | Multiple myeloma |
| MMP | Matrix metalloproteinase |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLS | Nuclear localization signal |
| OS | Osteosarcoma |
| OXPHOS | Oxidative phosphorylation |
| PC | Prostate cancer |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDGF | Platelet-derived growth factor |
| PI3K | PhosphoInositide 3-kinase |
| SATB2 | Special AT-rich sequence-binding protein 2 |
| SGK | Serum/glucocorticoid-regulated kinase |
| STAT3 | Signal transducer and activator of transcription 3 |
| TAM | Tumor-associated macrophages |
| TGF-β | Transforming growth factor β |
| TNBC | Triple-negative breast cancer |
| TNFα | Tumor necrosis factor α |
| TβRI | TGF-β receptor type I |
| VEGF | Vascular endothelial growth factor |
| Vim | Vimentin |